https://arolstar52-zhtest.hf.space/index.php?action=history&feed=atom&title=MDMAR
MDMAR - 版本历史
2026-07-18T22:11:08Z
本wiki上该页面的版本历史
MediaWiki 1.43.9
https://arolstar52-zhtest.hf.space/index.php?title=MDMAR&diff=4545318&oldid=prev
imported>Jimmy-bot：机器人: 尚未清空的已重定向分类） （Cat:狡詐家藥物→Cat:策划药
2025-08-15T10:23:02Z
<p>机器人: 尚未清空的已重定向分类） （<a href="/index.php?title=Cat:%E7%8B%A1%E8%A9%90%E5%AE%B6%E8%97%A5%E7%89%A9&action=edit&redlink=1" class="new" title="Cat:狡詐家藥物（页面不存在）">Cat:狡詐家藥物</a>→<a href="/index.php?title=Cat:%E7%AD%96%E5%88%92%E8%8D%AF&action=edit&redlink=1" class="new" title="Cat:策划药（页面不存在）">Cat:策划药</a></p>
<p><b>新页面</b></p><div>{{Infobox drug<br />
| drug_name = 3',4'-Methylenedioxy-4-methylaminorex<br />
| image = MD4MAR_structure.png<br />
| width = <br />
| caption = <br />
<br />
<!-- Clinical data --><br />
| pronounce = <br />
| tradename = <br />
| Drugs.com = <br />
| MedlinePlus = <br />
| licence_CA = <br />
| licence_EU = <br />
| DailyMedID = <br />
| licence_US = <br />
| pregnancy_AU = <br />
| pregnancy_category = <br />
| dependency_liability = <br />
| addiction_liability = <br />
| routes_of_administration = <br />
| class = <br />
| ATC_prefix = <br />
| ATC_suffix = <br />
<br />
<!-- Legal status --><br />
| legal_status = <br />
<br />
<!-- Pharmacokinetic data --><br />
| bioavailability = <br />
| protein_bound = <br />
| metabolism = <br />
| metabolites = <br />
| onset = <br />
| elimination_half-life = <br />
| duration_of_action = <br />
| excretion = <br />
<br />
<!-- Identifiers --><br />
| CAS_number = 1445573-16-9<br />
| CAS_supplemental = <br />
| PubChem = 163190697<br />
| IUPHAR_ligand = <br />
| DrugBank = <br />
| ChemSpiderID = <br />
| UNII = <br />
| KEGG = <br />
| ChEBI = <br />
| ChEMBL = <br />
| NIAID_ChemDB = <br />
| PDB_ligand = <br />
| synonyms = <br />
<br />
<!-- Chemical data --><br />
| IUPAC_name = 5-(1,3-benzodioxol-5-yl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine<br />
| C=11 | H=12 | N=2 | O=3<br />
| SMILES = CC1C(OC(=N1)N)C2=CC3=C(C=C2)OCO3<br />
| StdInChI = 1S/C11H12N2O3/c1-6-10(16-11(12)13-6)7-2-3-8-9(4-7)15-5-14-8/h2-4,6,10H,5H2,1H3,(H2,12,13)<br />
| StdInChIKey = JFKNBDXNCLMRPL-UHFFFAOYSA-N<br />
}}<br />
'''{{PAGENAME}}'''（3',4'-Methylenedioxy-4-methylaminorex，3',4'-亚甲二氧基-4-甲基阿米雷司）是一种[[氮化合物|含氮]][[有机化合物]]，化学式[[C11H12N2O3|C<sub>11</sub>H<sub>12</sub>N<sub>2</sub>O<sub>3</sub>]]，属于[[阿米雷司]]衍生物。<ref>{{cite journal | vauthors = McLaughlin G, Morris N, Kavanagh PV, Power JD, Twamley B, O'Brien J, Talbot B, Dowling G, Mahony O, Brandt SD, Patrick J, Archer RP, Partilla JS, Baumann MH | display-authors = 6 | title = Synthesis, characterization, and monoamine transporter activity of the new psychoactive substance 3',4'-methylenedioxy-4-methylaminorex (MDMAR) | journal = Drug Testing and Analysis | volume = 7 | issue = 7 | pages = 555–64 | date = July 2015 | pmid = 25331619 | doi = 10.1002/dta.1732 | pmc = 5331736 }}</ref><ref name="pmid26482089">{{cite journal | vauthors = Zawilska JB, Andrzejczak D | title = Next generation of novel psychoactive substances on the horizon - A complex problem to face | journal = Drug and Alcohol Dependence | volume = 157 | issue = | pages = 1–17 | date = December 2015 | pmid = 26482089 | doi = 10.1016/j.drugalcdep.2015.09.030 }}</ref><ref>{{cite journal | vauthors = Maier J, Mayer FP, Brandt SD, Sitte HH | title = DARK Classics in Chemical Neuroscience: Aminorex Analogues | journal = ACS Chemical Neuroscience | volume = 9 | issue = 10 | pages = 2484–2502 | date = October 2018 | pmid = 30269490 | doi = 10.1021/acschemneuro.8b00415 | pmc = 6287711 }}</ref><br />
<br />
==参考文献==<br />
{{reflist}}<br />
<br />
[[Category:策划药]]<br />
[[Category:苯并二𫫇茂]]<br />
[[Category:噁唑]]<br />
[[Category:胺]]</div>
imported>Jimmy-bot